Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2814

Sort by

Sort Order Select

Journal Articles

Frontline treatment of follicular lymphoma: what will it take to change current practice?

Emmanuel Bachy, Kim Linton

Blood (2025) 146 (15): 1770–1781.

https://doi.org/10.1182/blood.2024026019

Published: 2025

Journal Articles

The future of follicular lymphoma management: strategies on the horizon

Erin Mulvey, Sarah C. Rutherford, John P. Leonard

Blood (2025) 146 (15): 1792–1801.

https://doi.org/10.1182/blood.2024026017

Published: 2025

Journal Articles

End points and outcomes in follicular lymphoma: what should we measure, how, and why?

Mengyang Di, Matthew J. Maurer, Christopher R. Flowers

Blood (2025) 146 (15): 1802–1811.

https://doi.org/10.1182/blood.2024026978

Published: 2025

Journal Articles

Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics

Ferran Araujo-Ayala, Wendy Béguelin

Blood (2025) 146 (15): 1759–1769.

https://doi.org/10.1182/blood.2024026020

Published: 2025

Journal Articles

An updated understanding of follicular lymphoma transformation

Erin M. Parry, Jessica Okosun

Blood (2025) 146 (15): 1812–1823.

https://doi.org/10.1182/blood.2024026016

Published: 2025

Journal Articles

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

Blood (2025) 146 (15): 1747–1758.

https://doi.org/10.1182/blood.2025028313

Published: 2025

Includes: Supplemental data

Journal Articles

Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics

Raymond K. H. Yip, Jeremy Er, Lei Qin, Quoc Hoang Nguyen, Allan Motyer, Joel S. Rimes, Amanda Light, Ruvimbo D. Mishi, Ling Ling, Casey J. A. Anttila, Ellen Tsui, Daniela Amann-Zalcenstein, Mark R. Dowling, Kelly L. Rogers, Rory Bowden, Yunshun Chen, Simon J. Harrison, Edwin D. Hawkins

Blood (2025) 146 (15): 1837–1849.

https://doi.org/10.1182/blood.2025028896

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma

Blood (2025) 146 (15): 1824–1836.

https://doi.org/10.1182/blood.2025028863

Published: 2025

Includes: Supplemental data

Journal Articles

Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?

Carla Casulo, Laurie H. Sehn

Blood (2025) 146 (15): 1782–1791.

https://doi.org/10.1182/blood.2024026018

Published: 2025

Journal Articles

T-large granular lymphocytic leukemia transformation to peripheral T-cell lymphoma

Min Shi, Karen L. Rech

Blood (2025) 146 (15): 1868.

https://doi.org/10.1182/blood.2025030173

Published: 2025

Journal Articles

Introduction to a review series on follicular lymphoma: solved or insoluble problem?

Philippe Armand

Blood (2025) 146 (15): 1739–1740.

https://doi.org/10.1182/blood.2025030824

Published: 2025

Journal Articles

Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone

Blood blood.2025030113.

https://doi.org/10.1182/blood.2025030113

Published: 2025

Includes: Supplemental data

Journal Articles

Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

Blood (2025) 146 (14): 1677–1686.

https://doi.org/10.1182/blood.2025028330

Published: 2025

Includes: Supplemental data

Journal Articles

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion

Blood (2025) 146 (14): 1664–1676.

https://doi.org/10.1182/blood.2025028790

Published: 2025

Includes: Supplemental data

Journal Articles

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

Julia J. Scarisbrick, Pietro Quaglino, Sean Whittaker, Martine Bagot, Emmanuella Guenova, Evangelia Papadavid, Henry Miles Prince, Jose A. Sanches, Denis R. Miyashiro, Octavio Servitje, Christiane Querfeld, Oleg Akilov, Arvind Arumainathan, Luke Bennett, Maxime Battistella, Kim Benstead, Emilio Berti, Marie Beylot-Barry, Anne-Marie Busschots, Richard Cowan, Reinhard Dummer, Giles Dunnill, Teresa Estrach, Felicity Evison, Abraham Bashir, Larisa Geskin, Ale Gru, Joan Guitart, Melba C. Herrera, Emillia Hodak, Steve Horwitz, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Pam Mckay, Marta Marschalkó, Cesare Massone, Rubeta Matin, Christina Mitteldorf, Robert Novoa, Pablo Ortiz-Romero, Nicola Pimpinelli, Ramon M. Pujol, Annmari Ranki, Liisa Vakeva, Kerri E. Rieger, Rudolf Stadler, Franz Trautinger, Johanna Latzka, Maarten Vermeer, Rachel Wachsmuth, Sophie Weatherhead, Ulrike Wehkamp, Marion Wobser, Youn H. Kim

Blood (2025) 146 (14): 1687–1692.

https://doi.org/10.1182/blood.2025029628

Published: 2025

Includes: Supplemental data

Journal Articles

The Biology of MZL subtypes: Challenge and Relevance of Classification

Camille Laurent, Francesco Bertoni

Blood blood.2024028268.

https://doi.org/10.1182/blood.2024028268

Published: 2025

Includes: Supplemental data

Journal Articles

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Blood blood.2025028848.

https://doi.org/10.1182/blood.2025028848

Published: 2025

Journal Articles

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma

Blood (2025) 146 (13): 1575–1585.

https://doi.org/10.1182/blood.2024028107

Published: 2025

Includes: Supplemental data

Journal Articles

Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia

Blood blood.2025030177.

https://doi.org/10.1182/blood.2025030177

Published: 2025

Includes: Supplemental data

Journal Articles

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma

Blood (2025) 146 (13): 1586–1600.

https://doi.org/10.1182/blood.2025028412

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Frontline treatment of follicular lymphoma: what will it take to change current practice?

The future of follicular lymphoma management: strategies on the horizon

End points and outcomes in follicular lymphoma: what should we measure, how, and why?

Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics

An updated understanding of follicular lymphoma transformation

High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial

Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomics

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma

Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?

T-large granular lymphocytic leukemia transformation to peripheral T-cell lymphoma

Introduction to a review series on follicular lymphoma: solved or insoluble problem?

Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone

Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

The Biology of MZL subtypes: Challenge and Relevance of Classification

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma

Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia

Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only